View in Other Languages

Marshall Edwards, Inc.

NASDAQ:MSHLD ISIN:US5723224029

Marshall Edwards, Inc. (NASDAQ:MSHL) is developing novel cancer therapeutics based on the central design of naturally occurring compounds called isoflavones. These compounds are believed to interact with specific enzyme targets resulting in inhibition of tumor cell metabolism – a function critical for the survival of cancer cells.

  

News

Asian Activities Report for September 29, 2011: Red Mountain Mining (ASX:RMX) to Follow Up Significant Gold Mineralisation at Zhongqu Project Stage II Drilling in China

🕔9/29/2011 12:00:16 PM 11262

Asian Activities Report for September 29, 2011 includes: Red Mountain Mining Limited (ASX:RMX) will commence a Stage II underground drilling program on 29 September 2011 at the Zhongqu project in Gansu Province, China; Atlantic Limited (ASX:ATI) has signed an agreement to undertake a development study of Vietnam's bauxite extraction and supply chain industry, particularly in the Central Highlands of the country; Rico Resources Limited (ASX:RRI) has commenced a major resource definition drilling programme at the Wonmunna Project in the East Pilbara iron ore mining region; Rift Valley Resources Limited (ASX:RFV) today announced the acquisition of two new gold projects in the Lake Victoria Goldfields region of Tanzania; Novogen Limited (ASX:NRT) (NASDAQ:NVGN) will invest US$2 million in Marshall Edwards (NASDAQ:MSHL) to support ongoing medical research; Pipavav Defence and Offshore Engineering Company Limited (BOM:533107) and Airbus will develop state-of-the-art Maintenance, Repair and Overhaul facilities and associated infrastructure in India.

Read Full Article

Asian Activities Report for July 28, 2011: Novogen Limited (ASX:NRT) Announce Results of Pre-Clinical Studies in Chemotherapy-Resistant Ovarian Cancer Stem Cells

🕔7/28/2011 12:02:50 PM 9745

Asian Activities Report for July 28, 2011 includes: Novogen Limited's (ASX:NRT) subsidiary, Marshall Edwards, Inc.(NASDAQ:MSHL) announced the publication of results from a pre-clinical study of NV-128; Anatolia Energy Limited (ASX:AEK) announced an initial JORC Mineral Resource estimate for the Temrezli uranium prospect in Turkey; Waratah Resources Limited (ASX:WGO) has signed a binding Share Sale Agreement to acquire the Okanabora Project in the Republic of Congo; David Jones Limited (ASX:DJS) is launching a new brand campaign for Spring/Summer 2011.

Read Full Article
###

46,412 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 9) (Last 30 Days: 36) (Since Published: 8553) 

Company Data

    Principal Sector
  • Health & Pharm General 
  • Principal Industry
  • None 

Social Media